Clinical trial
Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)
NCT00097552 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Subjects With Turner Syndrome Treated With Growth Hormone in the National Cooperative Growth Study (NCGS)
- Lead sponsor
- Genentech, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 1997
- Completion date
- July 31, 2010
- Enrollment
- 1,696 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.